The petition of the day is: Mylan Pharmaceuticals Inc. v. Acorda Therapeutics Inc. 16-360 Issue: Whether the mere filing of an abbreviated new drug application by a generic pharmaceutical manufacturer is sufficient to subject the manufacturer to specific personal jurisdiction in any state where it might someday market the drug.